Thyroid Diseases: Clinical Trials

19 trials for Thyroid Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 recruiting, 5 unknown, 3 active not recruiting, 3 completed. 19 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 119Recruiting 6, Unknown 5, Active not recruiting 3, Completed 3, Terminated 2

Follow Thyroid Diseases: new trials by email Literature Review of Thyroid Diseases trials Research Report on Thyroid Diseases

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
INN805 - Maligant Solid Tumor, Head & Neck Cancer
Early Phase 1RecruitingFindCure Biosciences (ZhongShan) Co., Ltd.102026-04-202026-09-04
In Vivo CAR-T for Refractory Graves' Disease
In Vivo CAR-T Therapy - Graves' Disease
Early Phase 1RecruitingShanghai Zhongshan Hospital52026-01-292026-03-19
Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease
allogenic anti-CD19/BCMA CAR-T - Graves' Disease
Early Phase 1RecruitingShanghai Zhongshan Hospital42025-12-192026-01-05
Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease
Allogeneic CAR-T - Graves Disease
Early Phase 1RecruitingShanghai Zhongshan Hospital52025-08-102025-08-19
Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer
177Lu-LNC1004 Injection - Radioiodine Refractory Differentiated Thyroid Cancer
Early Phase 1RecruitingPeking Union Medical College Hospital202025-03-242025-04-15
Clinical Efficacy of Darqeen Capsule for the Management of Hypothyroidism Associated with Female Reproductive Hormonal Imbalance
Darqeen Capsule - Hypothyroidism
Early Phase 1Active not recruitingHamdard University502024-07-022025-02-13
MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin
Dapagliflozin 10mg Tab, Placebo, Levothyroxine Replacement daily - Hepatic Steato-Fibrosis, Non-Alcoholic Fatty Liver Disease
Early Phase 1Active not recruitingPost Graduate Institute of Medical Education and Research, Chandigarh502024-01-152026-08-28
Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy.
Rapamycin, Methylprednisolone - Graves Ophthalmopathy
Early Phase 1UnknownFirst Affiliated Hospital Xi'an Jiaotong University1402022-09-012022-09-08
Vit D Role in Post Thyroidectomy Hypocalcemia
vit D - Thyroid Diseases
Early Phase 1UnknownAssiut University302019-10-012019-09-19
Exparel Injection Effect on Postoperative Opioid Usage
Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine, Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine - Thyroid, Parathyroid Adenoma
Early Phase 1UnknownUniversity of Missouri-Columbia1002019-09-302024-07-29
the Microbiota Are Associated With Iodine-131 Therapy and Hypothyroidism
Probiotic - Microbiota
Early Phase 1UnknownFirst Affiliated Hospital of Harbin Medical University302018-05-012018-07-16
Bimatoprost as a Treatment for Graves' Orbitopathy
Bimatoprost Ophthalmic - Graves Ophthalmopathy
Early Phase 1RecruitingJohns Hopkins University32017-11-012026-07-16
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
Durvalumab (Medi4736), Radioiodine (RAI) - Thyroid Cancer
Early Phase 1Active not recruitingMemorial Sloan Kettering Cancer Center112017-07-102026-08-11
Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study
Vemurafenib, serial 124I PET/CT, thyrotropin alpha - Thyroid Carcinoma
Early Phase 1CompletedMemorial Sloan Kettering Cancer Center122014-05-202025-06-18
BRAF V600E Mutations In Papillary Thyroid Carcinoma
BRAF V600E POSITIVITY - Papillary Thyroid Carcinoma
Early Phase 1UnknownBezmialem Vakif University1502011-07-012011-08-16
Effect of Age, Weight and Sex on Levothyroxine Pharmacokinetics
Administration of stable Isotope labeled levothyroxine - Hypothyroidism Primary
Early Phase 1CompletedGeorgetown University412011-05-312017-04-06
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression
Bexarotene - Thyroid Cancer
Early Phase 1CompletedUniversity of Colorado, Denver102008-11-012014-01-17
DIM as a Treatment for Thyroid Disease
Diindolylmethane (DIM) - Proliferative Thyroid Disease
Early Phase 1TerminatedThe New York Eye & Ear Infirmary72006-11-012013-05-03
High Intensity Focused Ultrasound Device in Patients With Autonomous Hyperfunctioning Thyroid Nodules
HIFU - Autonomous Hyperfunctioning Thyroid Nodules
Early Phase 1TerminatedTheraclion22006-06-012014-06-23

Narrower conditions

Thyroid Neoplasms (6)  ·  Graves Disease (3)  ·  Hypothyroidism (3)  ·  Aggression (2)  ·  Graves Ophthalmopathy (2)  ·  Breast Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Heterotaxy Syndrome (1)  ·  Infertility, Female (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Parathyroid Neoplasms (1)  ·  Sarcoma (1)  ·  Thyroid Cancer, Papillary (1)

Broader conditions

Endocrine System Diseases (19)  ·  Endocrine Gland Neoplasms (8)  ·  Neoplasms (8)  ·  Neoplasms by Site (8)  ·  Head and Neck Neoplasms (7)  ·  Autoimmune Diseases (5)  ·  Exophthalmos (5)  ·  Eye Diseases (5)  ·  Goiter (5)  ·  Hyperthyroidism (5)  ·  Immune System Diseases (5)  ·  Orbital Diseases (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Aberrant Motor Behavior in Dementia (2)

Interventions

3,3'-diindolylmethane (1)  ·  Bexarotene (1)  ·  Iodine-131 (1)  ·  Methylprednisolone (1)  ·  Probiotics (1)  ·  Sirolimus (1)  ·  Thyrotropin Alfa (1)  ·  Thyroxine (1)  ·  Vemurafenib (1)  ·  dapagliflozin (1)  ·  durvalumab (1)

Sponsors

Shanghai Zhongshan Hospital (3)  ·  Memorial Sloan Kettering Cancer Center (2)  ·  Assiut University (1)  ·  Bezmialem Vakif University (1)  ·  FindCure Biosciences (ZhongShan) Co., Ltd. (1)  ·  First Affiliated Hospital Xi'an Jiaotong University (1)  ·  First Affiliated Hospital of Harbin Medical University (1)  ·  Georgetown University (1)  ·  Hamdard University (1)  ·  Johns Hopkins University (1)  ·  Peking Union Medical College Hospital (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  The New York Eye & Ear Infirmary (1)  ·  Theraclion (1)  ·  University of Colorado, Denver (1)

Countries

China (7)  ·  United States (6)  ·  Egypt (1)  ·  France (1)  ·  India (1)  ·  Pakistan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Alan Ho, MD, PhD (1)  ·  Alan L. Ho, MD, PhD (1)  ·  Ashu Rastogi, MD,DM (1)  ·  Bingyin Shi (1)  ·  Emily Li, MD (1)  ·  Joshua Klopper, MD (1)  ·  Stimson P. Schantz, MD (1)  ·  Tabitha Galloway, MD (1)  ·  Xiaoying LI, MD, PhD (1)  ·  Yunwei Wei (1)

Results publications

PMID 23140919, PMID 26365947, PMID 30256977, PMID 30813146, PMID 31492617, PMID 31494332, PMID 35350100